Mymetics Corp (MYMX)

[Work Harder]

Enrollment for HVTN 703/HPTN 081 (sub-Saharan African women) and HVTN 704/HPTN 085 (North and South American MSM) is proceeding well.

and trispecific antibodies

In the HVTN 094 trial, which tested the

GeoVax

DNA/MVA VLP vaccine using GM-CSF as an adjuvant with either two or three MVA boosts

antibody responses were generally directed toward gp41 and were durable for 12 months, while gp120 responses decayed more rapidly

http://europepmc.org/articles/PMC5564036/